| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1fd34fea6801ea1d9286475b96be2d26 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-385 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate |
1994-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d775054b12eec2dec7b4133c94fc23c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8184335b13e5c87f4de5f1cdd36500e |
| publicationDate |
1995-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0667155-A1 |
| titleOfInvention |
Tablets containing thioctic acid with a specified size |
| abstract |
The invention relates to a pharmaceutical formulation in the form of tablets containing thioctic acid (alpha-lipoic acid) with a content between 45% by weight and 99.9% by weight of active ingredient.n n n The invention is characterized in that 20% to 100% of the active ingredient used have a particle size between 100 µm and 710 µm, preferably 30% to 80% have a particle size between 200 µm and 710 µm. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0858802-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0858802-A2 |
| priorityDate |
1994-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |